Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
SI-Bone participates in a conference call with Truist » 12:25
03/31/21
03/31
12:25
03/31/21
12:25
SIBN

SI-Bone

$33.40 /

+1.29 (+4.02%)

Conference call with…

Conference call with management will be held on March 31 at 1 pm hosted by Truist.

ShowHide Related Items >><<
SIBN SI-Bone
$33.40 /

+1.29 (+4.02%)

SIBN SI-Bone
$33.40 /

+1.29 (+4.02%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$33.40 /

+1.29 (+4.02%)

  • 15
    Oct
SIBN SI-Bone
$33.40 /

+1.29 (+4.02%)

Conference/Events
SI-Bone participates in a conference call with Truist » 04:55
03/31/21
03/31
04:55
03/31/21
04:55
SIBN

SI-Bone

$31.93 /

+0.78 (+2.50%)

Conference call with…

Conference call with management will be held on March 31 at 1 pm hosted by Truist.

ShowHide Related Items >><<
SIBN SI-Bone
$31.93 /

+0.78 (+2.50%)

SIBN SI-Bone
$31.93 /

+0.78 (+2.50%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$31.93 /

+0.78 (+2.50%)

  • 15
    Oct
SIBN SI-Bone
$31.93 /

+0.78 (+2.50%)

Conference/Events
SI-Bone participates in a conference call with Truist » 12:55
03/26/21
03/26
12:55
03/26/21
12:55
SIBN

SI-Bone

$29.59 /

-0.45 (-1.50%)

Conference call with…

Conference call with management will be held on March 31 at 1 pm hosted by Truist.

ShowHide Related Items >><<
SIBN SI-Bone
$29.59 /

-0.45 (-1.50%)

SIBN SI-Bone
$29.59 /

-0.45 (-1.50%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$29.59 /

-0.45 (-1.50%)

  • 15
    Oct
SIBN SI-Bone
$29.59 /

-0.45 (-1.50%)

Over a month ago
Syndicate
SI-Bone requests withdrawal of registration statement » 16:09
03/18/21
03/18
16:09
03/18/21
16:09
SIBN

SI-Bone

$33.31 /

+1.33 (+4.16%)

SI-Bone requested the SEC…

SI-Bone requested the SEC consent to the immediate withdrawal of the company's registration statement on Form S-3, filed by the company on March 10. The first registration statement was inadvertently filed by the company using the filing code "S-3" rather than "S-3ASR" and the company, upon becoming aware of the use of the wrong code, has filed a new registration statement on Form S-3 on March 12, using the correct filing code "S-3ASR."

ShowHide Related Items >><<
SIBN SI-Bone
$33.31 /

+1.33 (+4.16%)

SIBN SI-Bone
$33.31 /

+1.33 (+4.16%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$33.31 /

+1.33 (+4.16%)

  • 15
    Oct
SIBN SI-Bone
$33.31 /

+1.33 (+4.16%)

Syndicate
SI-Bone files automatic mixed securities shelf  16:04
03/12/21
03/12
16:04
03/12/21
16:04
SIBN

SI-Bone

$31.46 /

+0.19 (+0.61%)

 
ShowHide Related Items >><<
SIBN SI-Bone
$31.46 /

+0.19 (+0.61%)

SIBN SI-Bone
$31.46 /

+0.19 (+0.61%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$31.46 /

+0.19 (+0.61%)

  • 15
    Oct
SIBN SI-Bone
$31.46 /

+0.19 (+0.61%)

Syndicate
SI-Bone files automatic mixed securities shelf  16:55
03/10/21
03/10
16:55
03/10/21
16:55
SIBN

SI-Bone

$30.75 /

+0.23 (+0.75%)

 
ShowHide Related Items >><<
SIBN SI-Bone
$30.75 /

+0.23 (+0.75%)

SIBN SI-Bone
$30.75 /

+0.23 (+0.75%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$30.75 /

+0.23 (+0.75%)

  • 15
    Oct
SIBN SI-Bone
$30.75 /

+0.23 (+0.75%)

Earnings
SI-Bone sees FY21 revenue $92M-$94M, consensus $94.78M » 16:06
03/08/21
03/08
16:06
03/08/21
16:06
SIBN

SI-Bone

$29.14 /

-0.24 (-0.82%)

The company said,…

The company said, "While SI-BONE has continued to see positive trends in its business, COVID-19 has had and may continue to have an impact on our business. The impact of the COVID-19 pandemic on the Company's business has differed by geography and region. The Company's 2021 outlook is highly sensitive to assumptions on a global recovery, which anticipates more normalized case scheduling and elective procedure levels progressing throughout the year. Based on these assumptions, the Company expects total 2021 revenue of approximately $92 million to $94 million, representing growth of 25% to 28% compared to full year 2020."

ShowHide Related Items >><<
SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

  • 15
    Oct
SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

Earnings
SI-Bone reports Q4 EPS (28c), consensus (30c) » 16:04
03/08/21
03/08
16:04
03/08/21
16:04
SIBN

SI-Bone

$29.14 /

-0.24 (-0.82%)

Reports Q4 revenue…

Reports Q4 revenue $22.14M, consensus $22.08M. "The fourth quarter was another successful period for SI-BONE as the company generated record quarterly revenues of $22.1 million," said Jeff Dunn, President, CEO and chairman of SI-BONE. "We continue to see strong underlying momentum in our business despite the lingering effects of the COVID-19 pandemic. As we move into 2021, we remain focused on executing our long-term strategic plan to drive growth and expand the market with our novel minimally invasive SI joint fusion therapy. As well, in January we announced the senior leadership transition plan that will make Laura Francis CEO and Tony Recupero President of Commercial Operations on or before May 1st. As Executive Chairman, I look forward to remaining highly engaged with SI-BONE and supporting Laura and Tony in their new roles."

ShowHide Related Items >><<
SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

  • 15
    Oct
SIBN SI-Bone
$29.14 /

-0.24 (-0.82%)

Hot Stocks
SI-Bone Chairman Dunn sells $1.3M in shares » 17:41
02/09/21
02/09
17:41
02/09/21
17:41
SIBN

SI-Bone

$32.14 /

-0.61 (-1.86%)

SI-Bone Chairman Jeffrey…

SI-Bone Chairman Jeffrey Dunn disclosed in a filing that he had sold 40,000 shares of company stock for $32.53 per share on February 5 for a total transaction amount of $1,301,396.

ShowHide Related Items >><<
SIBN SI-Bone
$32.14 /

-0.61 (-1.86%)

SIBN SI-Bone
$32.14 /

-0.61 (-1.86%)

01/08/21 JMP Securities
SI-Bone price target raised to $35 from $27 at JMP Securities
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
SIBN SI-Bone
$32.14 /

-0.61 (-1.86%)

  • 15
    Oct
SIBN SI-Bone
$32.14 /

-0.61 (-1.86%)

Over a quarter ago
Recommendations
SI-Bone price target raised to $35 from $27 at JMP Securities » 06:28
01/08/21
01/08
06:28
01/08/21
06:28
SIBN

SI-Bone

$29.01 /

+0.205 (+0.71%)

JMP Securities analyst…

JMP Securities analyst David Turkaly raised the firm's price target on SI-Bone to $35 from $27 and keeps an Outperform rating on the shares following the release of the company's preliminary Q4 results and reiterated FY20 guidance. The analyst believes SI-Bone should be primed to achieve 25%-30% y/y growth in 2021 and 2022, given the momentum created from recent key reimbursement updates, market-leading clinical evidence, maturing reps, and readily accessible surgeon training.

ShowHide Related Items >><<
SIBN SI-Bone
$29.01 /

+0.205 (+0.71%)

SIBN SI-Bone
$29.01 /

+0.205 (+0.71%)

12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
12/16/20 Needham
SI-Bone price target raised to $35 from $28 at Needham
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
09/30/20 JMP Securities
SI-Bone price target raised to $27 from $22 at JMP Securities
SIBN SI-Bone
$29.01 /

+0.205 (+0.71%)

  • 15
    Oct
  • 23
    Jan
SIBN SI-Bone
$29.01 /

+0.205 (+0.71%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.